Gmo Emerging Valuation
| GMAQX Fund | USD 14.19 0.19 1.32% |
At this time, the entity appears to be overvalued. Gmo Emerging Markets retains a regular Real Value of $13.24 per share. The prevalent price of the fund is $14.19. We determine the value of Gmo Emerging Markets from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Overvalued
Today
Please note that Gmo Emerging's price fluctuation is very steady at this time. At this time, the entity appears to be overvalued. Gmo Emerging Markets retains a regular Real Value of $13.24 per share. The prevalent price of the fund is $14.19. We determine the value of Gmo Emerging Markets from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Gmo Emerging is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gmo Mutual Fund. However, Gmo Emerging's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.19 | Real 13.24 | Hype 14.38 | Naive 14.37 |
The intrinsic value of Gmo Emerging's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gmo Emerging's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Gmo Emerging Markets helps investors to forecast how Gmo mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gmo Emerging more accurately as focusing exclusively on Gmo Emerging's fundamentals will not take into account other important factors: About Gmo Emerging Valuation
Our relative valuation model uses a comparative analysis of Gmo Emerging. We calculate exposure to Gmo Emerging's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Gmo Emerging's related companies.Under normal circumstances at least 80 percent of the funds net assets directly and indirectly in companies tied economically to markets that are not treated as developed markets in the MSCI World Index, with the exception of China . It may also invest In U.S. Treasury fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds. The fund is non-diversified.
Other Information on Investing in Gmo Mutual Fund
Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |